MedTrace Logo

Clinical Relevance of Scratching and Sleep in Atopic Dermatitis

NCT05467046 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2024-04-03

No results posted yet for this study

Summary

Atopic Dermatitis (AD), otherwise known as (atopic) eczema, is a chronic relapsing inflammatory skin disease. For difficult-to-treat AD, treatment options are limited. A better understanding of the underlying immunological cause, led to development of new, targeted therapies. For evaluating effectiveness and making treatment decisions for these new therapies, only 2 subjective methods exist: 1. clinical scores (AD-severity scored by a physician using structured scoring system), 2. questionnaires (completed by AD-patients). Therefore, an objective AD-severity assessment method might provide benefits for clinical practice.

In this study, it is evaluated whether scratching and sleep parameters, obtained with a smartwatch worn by AD-patients, provide added value for clinical practice in dermatology. The usability of this smartwatch system is evaluated by AD-patients.

Conditions

Interventions

DEVICE

Smartwatch system

The Atopic Dermatitis patient cohort is exposed to using a smartwatch system for 5 weeks.

Sponsors & Collaborators

  • UMC Utrecht

    collaborator OTHER

  • Philips Electronics Nederland B.V. acting through Philips CTO organization

    lead INDUSTRY

Principal Investigators

  • Marjolein de Buin-Weller, MD, PhD · University Medical Center Utrecht (UMC Utrecht)

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-03
Primary Completion
2023-09-30
Completion
2023-12-07

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05467046 on ClinicalTrials.gov